Salt form and crystal form of FGFR4 inhibitor compound, and preparation method thereof
WO2018090973A1
Fgfr4 inhibitor and preparation method and use thereof
CN110023288A
Crystal form, salt form and the preparation method of tyrosine kinase inhibitor
WO2017050224A1
Salt form and crystal form of quinoline derivative, preparation method therefor, and intermediate
CN106349466A
Novel preparation method of biological medical polyether/polyester segmented copolymer
CN106389355A
Polymeric micelle freeze-dried preparation of taxane anti-tumor drugs as well as preparation method and application of polymeric micelle freeze-dried preparation
TW201643168A
Fused-ring or tricyclic aryl pyridine compuond used as kinase inhibitor
WO2016169514A1
Imidazole compound
US2018354953A1
Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor
EP3293177A1
Tyrosine kinase inhibitor and pharmaceutical composition comprising same
US2018098990A1
Histone deacetylase inhibitor, and preparation method and use thereof
CN106045923A
Histone deacetylase inhibitor, and preparation method and application thereof
CN105732809A
Antibody for resisting platelet derived growth factor (PDGF)
CN105566322A
Preparation method of moxifloxacin impurity G compound
SG11201607973XA
Quinoline derivatives as smo inhibitors
CN104292293A
Preparation method of dutasteride impurity I
CN104231033A
Preparation method of dutasteride
CN104262346A
Preparation method of bromfenac sodium dimer impurity
CN104147032A
Drug composition for preventing and treating related diseases of ischemic stroke as well as preparation method and applications thereof
CN104297360A
Detection method for compound Xueshuantong (thrombus clearing) preparation fingerprint chromatogram
